| URL | Priority | Change frequency | Last modified (GMT) |
|---|---|---|---|
| https://astx.com/astex-pharmaceuticals-reports-2013-first-quarter-financial-results/ | 20% | Monthly | 2016-12-01 16:36 |
| https://astx.com/2013-aacr-novel-small-molecule-dna-methylation-inhibitor-sgi-110-as-ovarian-cancer-chemosensitizer/ | 20% | Monthly | 2016-12-01 12:46 |
| https://astx.com/2013-aacr-at-iap-a-dual-ciap1-and-xiap-antagonist-with-oral-antitumor-activity-in-melanoma-models/ | 20% | Monthly | 2016-11-25 14:34 |
| https://astx.com/2013-aacr-in-vivo-immunomodulatory-activity-of-sgi-110-a-second-generation-hypomethylating-agent/ | 20% | Monthly | 2016-12-01 12:46 |
| https://astx.com/astex-pharmaceuticals-to-announce-2013-first-quarter-financial-results-on-april-29th/ | 20% | Monthly | 2016-12-01 16:36 |
| https://astx.com/astex-pharmaceuticals-provides-sgi-110-update/ | 20% | Monthly | 2016-11-24 12:49 |
| https://astx.com/astex-pharmaceuticals-pipeline-data-presentations-at-aacr/ | 20% | Monthly | 2016-11-24 12:50 |